Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Auto-immuunziekte geen contra-indicatie voor PD-(L)1-remmer
jul 2022 | Immuuntherapie